Jeff Wu was invited to give a lecture titled “In-vitro Studies of Skin Deposition & Permeation and Their Practicality”, at the NYSCC Scientific Program “In-vitro Modeling to Predict Clinical Outcome”, NYSCC Suppliers Day, May 2, 2022, New York City, USA

Neoventech exhibited at AAPS 2021, Philadelphia, PA on October 18-20. It was refreshing to be able to connect in-persons with its customers of pharmaceutical scientists and suppliers for its topical drug product development service after more than18 months due to…

CRS 2021 had another successful virtual meeting on July 25-29, 2021. https://2021.controlledreleasesociety.org/ Dr. Jeffrey Wu CEO of Neoventech, working as the Chair of CRS division of Consumer and Diversified Products (C&DP) has organized and moderated a technology symposium titled “Delivery…

CRS 2020, a premier international annual event (https://2020.controlledreleasesociety.org/) in delivery science and technology with the applications of drug delivery, pharmaceutical science, preclinical sciences and animal health had its successful virtual meeting June 29-July 1 in the face of the current…

Neoventech has signed an agreement with Pennsylvania (PA) Biotechnology Center to lease a lab facility for its new generic topical and cosmetic product development. PA Biotechnology Center is a life science incubator dedicated to the creation of a world-class biotechnology…

On November 22, FDA released the new draft guidance for “Transdermal and Topical Delivery Systems (TDS) – Product Development and Quality Considerations”. This is a useful guide to help the industry to deal with the complexity of the transdermal delivery…

Logan Instrument has announced its new all-in-one drug dissolution and permeation system – PERMETRO, it is automated and mimic permeation rates inside the gastrointestinal (GI) tract , may open up a lot of applications in our understanding of the transport and…